About
Sensydia is developing a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to gold standard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring.
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
Google Tag Manager
Wix
YouTube
Varnish
Mobile Friendly
Remote
Keywords
medical equipment manufacturing
non-invasive hemodynamics
clinical research
heart failure
point-of-care system
wireless sensors
patient outcomes
healthcare equipment & supplies
heart failure management
cardiac monitoring
clinical decision support
cost reduction
b2b
services
real-time data
automated detection
ai-driven diagnostics
early detection
cloud-based reporting
automated cardiac abnormality detection
hemodynamic parameters
healthtech
ejection fraction
cardiology
diagnosis and management
non-invasive cardiac assessment
machine learning algorithms
healthcare technology
cardiac performance system
medical devices
Company Information
-
Employees 14
-
Founded 2015
-
Annual Revenue $4000000
-
Total Funding $11000000
Location
10880 Wilshire Blvd, Los Angeles, California, United States, 90024
